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Recognition of microbial products by germ-line-encoded PRR initiates immune responses, but
how PRR mediate speciﬁc host responses to infectious agents is poorly understood.
We and others have proposed that speciﬁcity is achieved by collaborative responses mediated
between different PRR. One such example comprises the fungal b-glucan receptor Dectin-1,
which collaborates with TLR to induce TNF production. We show here that collaborative
responses mediated by Dectin-1 and TLR2 are more extensive than ﬁrst appreciated, and
result in enhanced IL-23, IL-6 and IL-10 production in DC, while down-regulating IL-12
relative to the levels produced by TLR ligation alone. Such down-regulation occurred with
multiple MyD88-coupled TLR, was dependent on signaling through Dectin-1 and also
occurred in macrophages. These ﬁndings explain how fungi can induce IL-23 and IL-6, while
suppressing IL-12, a combination which has previously been shown to contribute to the
development of Th17 responses found during fungal infections. Furthermore, these data
reveal how the collaboration of different PRR can tailor speciﬁc responses to infectious agents.
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Introduction
Recognition of microbial products by germ-line-encoded PRR
initiates host immune responses. The most intensively studied
group of PRR, the TLR, recognize a widely expressed range of
microbial structures [1]. Given that most TLR signal through a
common adaptor MyD88, it is unclear how recognition of these
structures can translate into speciﬁc responses required for effective
host defense. We and others have proposed that the collaboration of
different PRR induces speciﬁc host immune responses [2, 3]. For
example, co-ligation of TLR3, which couples to the adaptor TRIF
(TIR-domain-containing adapter-inducing interferon-b)a n dn o t
MyD88, with TLR7 synergistically induces IL-12 production and
promotes development of Th1 responses [4]. The b-glucan receptor,
Dectin-1 and TLR2 are another PRR pair, which act synergistically,
inducing the production of TNF [5].
Dectin-1 plays an essential role in the innate response to fungal
pathogens [6]. Recognition of fungal b-1,3-glucan by Dectin-1 can
induce phagocytosis, the respiratory burst and the production of
numerous cytokines and chemokines [7]. Signaling through
Dectin-1, which is largely mediated through Syk kinase, is thought
to be sufﬁcient for production of cytokines, such as IL-10, IL-6 and
IL-23 [7, 8], whereas others, such as TNF, additionally require the
recognition of another undeﬁned fungal component by TLR2, and
signaling through the MyD88 pathway [5]. During fungal infection
in mice, Dectin-1-mediated production of IL-23 and IL-6 promotes
the development of Th17 responses [8]. In line with this, human
memory responses to Candida albicans were found to be predo-
minantly Th17, and to a far lesser extent Th1 [9]. However, the
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understood. We show here that although stimulation of Dectin-1 is
sufﬁcient for the production of IL-10, IL-6 and IL-23, co-ligation
with TLR synergistically enhances these responses, while simulta-
neously down-regulating IL-12. These data provide a further
example of how pairs or sets of PRR can tailor speciﬁc responses to
infectious agents.
Results
Collaborative induction of IL-10 by the Dectin-1/Syk
and TLR2/MyD88 pathways
Signaling from Dectin-1 is sufﬁcient for the induction of
cytokines, such as IL-10 [10], but we speculated that these
responses may also be inﬂuenced by collaborative signaling with
TLR2, such as we have previously documented for the induction
of TNF [5]. For these experiments, we made use of highly puriﬁed
ligands speciﬁc for each receptor [5, 11] and determined the
effect of stimulating Dectin-1 and/or TLR2 on IL-10 production in
BM-derived DC (BMDC). As we reported previously [10],
stimulation of these cells with puriﬁed b-glucan induced the
production of IL-10 and this response was Dectin-1-dependent, as
cells lacking this receptor did not respond to these carbohydrates
(Fig. 1A). Both WT and Dectin-1
 /  BMDC produced comparable
levels of IL-10 in response to LPS, demonstrating that b-glucan is
a speciﬁc ligand in this system. Stimulation with TLR2-speciﬁc
ligand, Pam3CSK4, also induced the production of IL-10 [12],
particularly at higher concentrations (Fig. 1B). However,
combining this stimulus with b-glucan greatly enhanced IL-10
production, indicating that Dectin-1 and TLR2 were acting in a
synergistic fashion for the induction of this cytokine (Fig. 1B).
Although b-glucan-induced IL-10 production is Syk-dependent
[10], Dectin-1 can also signal via Syk-independent pathways [7],
so we examined the downstream signaling components involved in
the collaborative response, using BMDC from WT, Syk
 /  chimeric
and MyD88
 /  mice. b-Glucan stimulated IL-10 production in a
Syk-dependent fashion, as expected, but Syk-deﬁciency also abla-
ted the synergistic response obtained with the co-addition of low
concentrations of Pam3CSK4 (Fig. 1C). Similarly, synergistic IL-10
production was absent in MyD88
 /  DC, in which the response
was comparable to that obtained following b-glucan stimulation
alone (Fig. 1D). Thus, these results indicate that although Dectin-1
signaling is sufﬁcient for the production of IL-10, co-stimulation of
both the Dectin-1/Syk and TLR/MyD88 signaling pathways
synergistically enhances this response.
Co-ligation of Dectin-1 and TLR2 enhances IL-6 and
IL-23 but down-regulates IL-12
We then determined whether the production of other cytokines
previously shown to be induced by Dectin-1 could also be
inﬂuenced by co-stimulation with TLR2. We ﬁrst examined IL-6
[8], and found that the co-addition of b-glucan and Pam3CSK4
enhanced the production of this cytokine in a largely additive
manner (Fig. 2A). As before, this response was dependent on
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Figure 1. Collaborative induction of IL-10 by Dectin-1 and TLR2. (A) IL-10 production induced by 10mg/mL b-glucan or 1mg/mL LPS in 129/Sv WTand
129/Sv Dectin-1
 /  BMDC. (B) Production of IL-10 by C57BL/6 BMDC stimulated with the indicated concentrations of Pam3CSK4 with or without
10mg/mL b-glucan. Induction of IL-10 in Balb/C WT and Syk
 /  (C) or C57BL/6 WT and MyD88
 /  (D) BMDC following stimulation with 10mg/mL
b-glucan and 10ng/mL Pam3CSK4, as indicated. Data shown are mean7SD and are representative of two independent experiments.
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we have described previously [8], but this response could also be
synergistically enhanced following co-ligation of TLR2 (Fig. 2C).
We also examined the induction of IL-12, in which Dectin-1
has been implicated [13], but in contrast to the other cytokines,
we found that the production of IL-12 was paradoxically down-
regulated relative to levels induced by TLR2 stimulation alone
(Fig. 2D). As Dectin-1 is expressed on macrophages [14], we
wondered if co-stimulation of TLR2 and Dectin-1 would also
inﬂuence IL-12 production in these cells. Indeed, similar to that
which we observed in DC, IL-12 was down-regulated in macro-
phages, relative to the level induced after TLR2 stimulation with
Pam3CSK4 alone (data not shown, see Fig. 4). Consistent with all
these observations, we found that co-stimulation of Dectin-1 and
TLR2 on DC led to reduced levels of transcripts encoding p35, a
subunit of IL-12p70, while simultaneously increasing the level of
transcripts encoding p19, a subunit of IL-23 (Fig. 3A and B). By
contrast, co-ligation of Dectin-1 did not markedly affect the levels
of IL-12p40 transcripts (Fig. 3C). Thus co-stimulation of Dectin-1
and TLR2 enhances the production of IL-10, IL-6 and IL-23, but
down-regulates the production of IL-12.
Down-regulation of IL-12 requires signaling through
Dectin-1 and is independent of IL-10
We next examined the mechanism of IL-12 down-regulation and
investigated the roles of Syk kinase, ERK and PI3K. For this
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Figure 2. Co-ligation of Dectin-1 and TLR2 enhances production of IL-6 and IL-23 but down-regulates IL-12. (A) Production of IL-6 by C57BL/6 BMDC
stimulated with the indicated concentrations of Pam3CSK4 with or without 10mg/mL b-glucan. (B) IL-6 production induced by 10mg/mL b-glucan or
1mg/mL LPS in 129/Sv WT and Dectin-1
 /  BMDC. (C) Collaborative induction of IL-23 by C57BL/6 BMDC stimulated with the indicated
concentrations of Pam3CSK4 with or without 10mg/mL b-glucan. (D) Co-stimulation of C57BL/6 BMDC with the indicated concentrations of
Pam3CSK4 and 10mg/mL b-glucan down-regulates production of IL-12p70 relative to levels after Pam3CSK4 stimulation alone. Data shown are
mean7SD and are representative of at least two independent experiments.
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Figure 3. Co-ligation of Dectin-1 and TLR2 enhances IL-23p19 but down-regulates IL-12p35 at the transcriptional level. Real-time PCR data
showing the relative levels of transcripts of IL-23p19, IL-12p35 and IL-12p40 following stimulation of Balb/C BMDC with 100ng/mL Pam3CSK4 and/or
10mg/mL b-glucan, as indicated. Shown are mean7SEM of data pooled from two independent experiments.
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levels of IL-10 and IL-12 following stimulation through Dectin-1
alone, and hence give higher synergistic responses relative to the
responses following ligation of Dectin-1 alone. Syk kinase is
activated downstream of Dectin-1 [10] (Fig. 4A), whereas
activation of ERK occurs downstream of both Dectin-1 and
TLR2 [15, 16]. Activation of PI3K, indicated by Akt phosphoryla-
tion, can also be triggered by TLR2 [17] and Dectin-1 [18],
but appears to occur primarily through Dectin-1 in this system
(Fig. 4A). All of these kinases are known to regulate IL-10
[16, 19], and we could demonstrate that loss of Syk, or inhibition
of ERK or PI3K prevented the synergistic production of IL-10
(Fig. 4B). By contrast, the inhibition of IL-12 production observed
in WT macrophages after co-stimulation was largely lost in Syk-
deﬁcient macrophages (Fig. 4C).
Speciﬁc inhibition of PI3K with Ly294002 increased produc-
tion of IL-12 following TLR2 stimulation alone (Fig. 4C and
legend), consistent with previous reports that PI3K negatively
regulates IL-12 production [20]. However, in contrast to
untreated macrophages, the levels of IL-12 were comparable after
TLR2 stimulation and co-stimulation, suggesting that PI3K is
required for IL-12 down-regulation. Inhibition of ERK with
U0126 also increased the overall levels of IL-12 after TLR2
stimulation or co-ligation with Dectin-1, as expected [12, 15], but
the responses remained down-regulated after co-ligation relative
to the response after TLR2 ligation alone (Fig. 4C and legend).
Down-regulation of IL-12 in macrophages therefore appears to
require both Syk and PI3K, but not ERK.
We next examined these responses in DC and, as we had
observed in macrophages, inhibitors of these pathways blocked
IL-10 production following co-ligation of Dectin-1 and TLR2
(data not shown). We could also demonstrate that IL-12 down-
regulation in DC was mediated through Dectin-1, as this response
was lost in Dectin-1-deﬁcient cells (Fig. 4D). As before, inhibition
of ERK with U0126 had no effect on IL-12 down-regulation;
however, and in contrast to macrophages, the inhibition of PI3K
with Ly294002 did not affect IL-12 down-regulation following
receptor co-stimulation (Fig. 4D). These results therefore suggest
that, although the mechanisms mediating this response are
different, the down-regulation of IL-12 occurs in both of these cell
types and is dependent on signaling induced through Dectin-1.
One possible mechanism of IL-12 down-regulation following
receptor co-stimulation, is inhibition by the enhanced levels of
IL-10 [21]. However, as the inhibition of ERK did not affect IL-12
down-regulation, despite abolishing IL-10 production, our results
suggested that the effects on IL-12 were occurring independently
of IL-10. To conﬁrm this, we examined IL-12 production follow-
ing co-stimulation of Dectin-1 and TLR2 in IL-10
 /  DC.
As before, co-ligation of Dectin-1 and TLR2 in WT BMDC inhib-
ited IL-12 production, relative to stimulation via TLR2
alone; however, IL-12 was also down-regulated in IL-10
 / 
cells (Fig. 4E). Similar results were obtained with IL-10-
deﬁcient macrophages (data not shown). Thus IL-12 down-
regulation following receptor co-stimulation occurs indepen-
dently of IL-10.
Down-regulation of IL-12 occurs upon co-ligation of
Dectin-1 with multiple TLR
We have previously shown that co-ligation of Dectin-1 with
multiple MyD88-coupled TLR synergistically induces production
of TNF [5] and we therefore determined if down-regulation of
IL-12 also occurred under these conditions in macrophages.
Indeed, we found that the addition of b-glucan down-regulated
the production of IL-12 induced through multiple TLR, including
TLR2/1, TLR2/6, TLR4 and TLR7 (Fig. 5A).
To further examine the effect of Dectin-1 on TLR responses,
we then directly compared the induction of cytokines after co-
ligation of TLR7 with either TLR3 or Dectin-1 in BMDC. We chose
these PRR as collaboration of TLR7 with TLR3 has been
previously shown to synergistically induce the production of
IL-12 [4]. While co-ligation of TLR7 and TLR3 enhanced IL-12
responses, as expected, co-ligation of TLR7 and Dectin-1 down-
regulated the production of IL-12 relative to that induced by
TLR7 alone (Fig. 5B). Similarly, co-ligation of Dectin-1 down-
regulated the high levels of IL-12 induced by the combination of
TLR7 and TLR3 ligands. Thus Dectin-1 down-regulates the
production of IL-12 induced through multiple TLR in both
macrophages and DC.
Discussion
The recognition of fungal pathogens, such as C. albicans, involves
multiple receptors including several TLR and Dectin-1 [22]. We
show here that co-ligation of Dectin-1 with multiple TLR down-
regulates IL-12 production, while simultaneously enhancing
production of other cytokines such as IL-10, IL-6 and IL-23.
Although induction of IL-10, IL-6 and IL-23 through Dectin-1
in DC has been demonstrated before [8, 10], our data differ from
previous ﬁndings in that we show that optimal IL-10, IL-23 and
IL-6 production requires co-ligation of Dectin-1 and TLR, as
opposed to ligation of Dectin-1 alone. Our data compliment
recent studies that demonstrated that large particulate b-glucans
and cytokines, such as GM-CSF, which is often present in BMDC
cultures, enhances the responsiveness of Dectin-1 for production
of particular cytokines [23, 24]. Indeed, the relatively high levels
of IL-10, IL-23 and IL-6 observed previously [8, 10] might be
explained by the use of curdlan, a large particulate b-glucan, and
the presence of GM-CSF in the culture medium. Our assays, in the
absence of GM-CSF, show that co-ligation of TLR with Dectin-1 is
required for optimal cytokine production. Thus, whereas previous
studies have argued how single receptors inﬂuence responses, we
demonstrate that pairs or sets of receptors collaborate to induce
optimal cytokine responses.
As a second major ﬁnding of this paper, we show that PRR
combinations, while inducing IL-10, IL-23 and IL-6, suppress the
production IL-12. These results are similar to recent ﬁndings using
human DC demonstrating that co-ligation of Dectin-1 with TLR2
and TLR7/8 similarly down-regulates IL-12 while up-regulating
IL-23 [25]. However, in contrast to Gerosa et al. [25], we
Eur. J. Immunol. 2009. 39: 1379–1386 Kevin M. Dennehy et al. 1382
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Figure 4. Down-regulation of IL-12 is dependent on signaling through Dectin-1. (A) Phosphorylation of Syk and Akt after stimulation of Balb/C
BMDC with 10mg/mL soluble b-glucan and 1mg/mL Pam3CSK4, as indicated. Production of IL-10 (B) and IL-12p70 (C) from Balb/C Syk
 /  or WT
thioglycollate-elicited macrophages pretreated with vehicle, 20mM U0126 or 20mM Ly294002, and stimulated with 10mg/mL b-glucan and 10ng/mL
Pam3CSK4, as indicated. (D) Production of IL-12p70 from Balb/C WT or 129Sv Dectin-1
 /  BMDC pretreated with vehicle, 20mM U0126 or 20mM
Ly294002, and stimulated with 10 mg/mL b-glucan and 100ng/mL Pam3CSK4, as indicated. (E) Production of IL-12p70 from Balb/C WT or IL-10
 / 
BMDC stimulated with 10mg/mL b-glucan and 100ng/mL Pam3CSK4, as indicated. Data shown are mean7SD and are representative of two
independent experiments.
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through a number of MyD88-coupled TLR (Fig. 5), and indeed
even following stimulation with both TLR7 and TLR3 ligands
which strongly up-regulate IL-12 (Fig. 5B). Because Gerosa et al.
[25] do not observe down-regulation of IL-12 following co-ligation
of Dectin-1 with any other TLR apart from TLR2, they suggest that
such down-regulation may be due to signaling through TLR2. In
contrast, we demonstrate that IL-12 down-regulation is mediated
by Dectin-1, using Dectin-1-deﬁcient cells (Fig. 4D). The consid-
erable differences between our ﬁndings and those of Gerosa et al.
[25] might be explained by the different species and stimulation
conditions that were used. For example, murine BMDC were
grown in GM-CSF which was removed prior to stimulation,
whereas human monocyte-derived DC were grown in GM-CSF and
IL-4 which were not removed prior to stimulation. Additionally,
the ligands for Dectin-1 were different. We used a highly puriﬁed
yeast-derived insoluble phagocytosible ligand, whereas Gerosa
et al. [25] used a commercially available b-glucan, which has not
been analyzed for purity. However, regardless of the differences
between these two studies, the underlying concept remains that
co-ligation of particular PRR can induce reciprocal regulation of
IL-12 and IL-23. Indeed, fungal hyphae and the fungal cell wall
preparation zymosan, which contain b-glucan and a number of
TLR ligands, have been shown to induce high levels of IL-23 while
concomitantly inducing low levels of IL-12 [9, 10, 25]. We argue
that the reciprocal regulation of these cytokines that we observe
here using pure ligands may explain how the production of these
cytokines is regulated by fungi.
We have not deﬁned a signaling mechanism by which IL-12 is
down-regulated following co-ligation of Dectin-1 and TLR.
However, we show in macrophages that such down-regulation
requires both Syk and PI3K, which are activated downstream of
Dectin-1. Recently it was shown that down-regulation of IL-12 in
macrophages following co-ligation of FcgR and TLR4 also requires
PI3K [19]. Given that PI3K is predominantly activated downstream
of FcgR in that system and Dectin-1 in our assays (Fig. 4A), the
mechanism of IL-12 inhibition in macrophages may be similar.
Moreover, down-regulation of IL-12 following co-ligation of FcgR
and TLR4 occurs independently of IL-10 [26], which we also
observed following co-ligation of Dectin-1 and the TLR (Fig. 4E
and data not shown). Thus the inhibition of IL-12 in macrophages
occurs independently of IL-10 and mechanistically appears similar
to that following TLR4 and FcgR ligation [19, 26].
In contrast to macrophages, down-regulation of IL-12
following co-ligation of Dectin-1 and TLR in DC was not depen-
dent on PI3K, ruling out a common mechanism in the two cell
types. While it is clear that IL-12 down-regulation is dependent
on the Dectin-1 pathway (Fig. 4D), the underlying mechanism in
these cells remains an open question.
Lastly, our results demonstrating reciprocal regulation of
cytokines following co-ligation of Dectin-1 and TLR are remark-
ably similar to recent reports demonstrating that co-ligation of
NOD2 and various TLR down-regulates IL-12 production while
concomitantly enhancing IL-23 production and promoting Th17
responses [27, 28]. Taken together with the present study, these
results suggest that such reciprocal regulation of cytokines by sets
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Figure 5. Down-regulation of IL-12 occurs following co-activation of Dectin-1 and multiple TLR. (A) Down-regulation of IL-12p70 following co-
stimulation of thiogylcollate-elicited peritoneal macrophages with 10mg/mL b-glucan (bG) and 100ng/mL Pam3CSK4 (TLR2/1), 100ng/mL FSL-1
(TLR2/6), 100ng/mL LPS (TLR4) or 0.5mg/mL CL-097 (TLR7), as indicated. p o 0.05 (Student’s t-test). (B) Production of IL-12p70 by Balb/C BMDC after
stimulation with 0.5mg/mL CL-097, 10mg/mL poly(I:C) or 10mg/mL b-glucan, as indicated. Data shown are mean7SD and are representative of two
independent experiments.
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responses. Given that both Dectin-1 and NOD2 signal through the
CARD9 (caspase recruitment domain 9) adaptor [29, 30], it
remains to be seen whether other CARD9-coupled receptors [31]
similarly collaborate with TLR to promote Th17 responses.
Materials and methods
Reagents and mice
All TLR ligands were from InvivoGen (San Diego, CA), and the
inhibitors U0126 and Ly294002 were from Calbiochem (Darm-
stadt, Germany). Production of highly puriﬁed particulate
b-glucan and soluble b-glucan (glucan phosphate) have been
described [11]. Balb/C, Balb/C IL-10
 / , C57BL/6 and C57BL/6
MyD88
 / , 129/Sv and 129/Sv Dectin-1
 /  [6] mice were
obtained from the animal unit of the University of Cape Town.
Balb/C Syk
 /  chimeric mice were generated by the transfer of
Syk
 /  fetal liver cells into irradiated Balb/C recipients, as
described [5]. All procedures were approved by the University of
Cape Town animal ethics committee.
Cell stimulation
Murine thioglycollate-elicited macrophages [32] were plated at
0.5–1 10
6cells/mL in RPMI 1640 medium containing 10% fetal
calf serum (Gibco) and incubated overnight. The medium was
replaced, and cells were stimulated with 10mg/mL particulate
b-glucan and 10ng/mL Pam3CSK4, unless otherwise indicated, for
20h. Immature murine BMDC were grown to 480% CD11c
1
MHCII
int as described [33], washed and incubated overnight in
RPMI 1640 medium containing 10% fetal calf serum, plated at
4 10
5cells/mL and stimulated for 20h. Cytokine secretion was
assayed by ELISA using kits from Becton Dickinson (Mountain
View, CA).
Real-time PCR
BMDC were plated at 10
6cells/mL in RPMI 1640 medium
containing 10% fetal calf serum (Gibco) and incubated overnight.
Medium was replaced, and cells were stimulated with 10mg/mL
particulate b-glucan and 100ng/mL Pam3CSK4 for 3h. Cells were
then lysed directly in Trizol LS (Invitrogen) and the RNA was
further puriﬁed using RNeasy (Qiagen) before ﬁrst strand cDNA
synthesis using oligo dT primers and the ImProm-II Reverse
Transcription System (Promega). Real-time PCR using Light-
Cycler FastStart DNA Master PLUS SYBR Green kit (Roche) was
performed using primers for IL-12a p35 (QuantiTect primer
QT01048334, Qiagen), IL-12b p40 (QuantiTect primer
QT00153643, Qiagen), IL-23 p19 [34] and ribosomal protein
S12 (forward 50-GGAAGGCATAGCTGCTGGAGG-30 and reverse
50-CGATGACATCCTTGGCCTGA-30; a kind gift of Dr. Anita
Schwegmann, University of Cape Town). Relative mRNA expres-
sion values were obtained by dividing the calculated transcript
levels by the rS12 levels for each sample, and results are
presented as fold change in transcript levels versus untreated
controls.
Syk and akt phosphorylation
BMDC (10
7 cells in 100mL HBSS) were stimulated with 10mg/mL
soluble b-glucan and 1mg/mL Pam3CSK4 for 3min at 371C before
addition of lysis buffer (1% NP40, 25mM Tris pH 8, 10mM
EDTA, 140mM NaCl, 5mM NaF, 1mM Na3VO4, 5mM iodoace-
tamide) containing protease inhibitors (Roche). Lysate super-
natants were resolved by SDS-PAGE, Western-blotted and probed
with antibodies to phospho-Syk and Syk or phospho-Akt (Ser473)
and Akt (Cell Signaling, MA).
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